Stay updated on IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page.

Latest updates to the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page’s displayed software/content revision updated from v3.5.2 to v3.5.3, reflecting a site-level release with no apparent change to the underlying study details shown.SummaryDifference0.1%

- Check16 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedAdded revision: v3.5.0 and removed revision: v3.4.3. This appears to be an administrative version update that does not affect the study details.SummaryDifference0.1%

- Check52 days agoChange DetectedThe header now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision: v3.4.2 has been added. The previous notices about government funding and Revision: v3.4.1 have been removed.SummaryDifference0.5%

- Check87 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center operations with links for updates. The page revision was updated to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

Stay in the know with updates to IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMMU-132+Carboplatin in Triple-Negative Breast Cancer Clinical Trial page.